Displaying 12661 - 12690 of 17006
-
-
Archive: KPIX-TV features UCSF gene therapy trial for Parkinson's disease
-
Archive: UCSF Psychiatrist Featured in Story About Teen Suicide
-
Archive: UCSF researchers identify a molecular link between thymic tumors and autoimmunity
UCSF researchers have identified a molecular mechanism that explains why patients with tumors of the thymus, or thymoma, often develop autoimmune disorders.
-
Archive: Greenspan to Receive American Association for Dental Research Scientist Award
John Greenspan, whose dental and oral health research has led to major contributions to HIV research and care, is the recipient of the 2010 American Association for Dental Research Distinguished Scientist Award.
-
Archive: Senator Specter Urges UCSF Community to Exert Political Power
Senator Arlen Specter visited UCSF last week talking about health care reform -- the topic of today’s nationally televised summit in Washington DC.
-
Archive: UCSF Primary Care Group Opens at Mount Zion, Accepts Patients
Two doctors are now accepting patients at a new primary care group practice at UCSF’s Mount Zion campus.
-
Archive: UCSF Medical Center CEO profiled in hospital magazine
-
Archive: New cancer-fighting strategy focuses on signaling molecules
Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors.
-
Archive: New Cancer Fighting Strategy Emerges from Antibody Signaling Discovery
A new discovery about cancer and the immune system points to previously unrecognized targets for drug development to battle solid tumors.
-
Archive: QB3 adds Zcube as limited partner in Mission Bay Capital Fund
Mission Bay Capital, LLC, has added a new limited partner to its first venture fund, bolstering the fund’s ability to invest in promising bioscience companies emerging from the University of California.
-
Archive: AP story on decline in primary care quotes UCSF physician
-
Archive: UC Answers Questions About Restart of Pension Contributions
Gary Schlimgen, director of pension and retirement programs at the University of California Office of the President, answers questions about the restart of contributions to the UC Retirement Plan. <a href="http://www.universityofcalifornia.edu/news/article/22856">Read more on the UC website</a>.
-
Archive: Chancellor Names Bluestone as Executive Vice Chancellor, Provost, Pending Approval by Regents
UCSF Chancellor Sue Desmond-Hellmann, MD, MPH, today named Jeffrey Bluestone as executive vice chancellor and provost, pending approval by the UC Regents.
-
Archive: Regional stories quote UCSF expert on health effects of 3-D glasses
-
Archive: Walter Newman, San Francisco community leader, joins NCIRE board
Walter S. Newman, a leading San Francisco businessman, philanthropist, and community leader, has joined the Board of Directors of NCIRE-The Veterans Health Research Institute.
-
Archive: American Association of Anatomists Elects Topp as Fellow
Kimbery Topp, chair of the Department of Physical Therapy and Rehabilitation Science, has been named a fellow of the American Association of Anatomists.
-
Archive: UCSF Nursing Dean participates in radio report on job shortage
-
Archive: UCSF Launches Family-Oriented Web Portal, Conducts Survey
UCSF has launched a family-friendly web portal and is conducting a survey on family needs with the goal of increasing the availability and access of family programs, services and events.
-
Archive: UCSF Seeks Nominees for Chancellor's GLBT Leadership Award
Nominations for the Chancellor’s Award for Gay, Lesbian, Bisexual and/or Transgender (GLBT) Leadership are due by 5 p.m. on March 31.
-
Archive: Depression in midlife linked with disability in old age
People with symptoms of depression in middle age have a significantly greater risk in old age of being physically disabled or unable to carry out tasks of daily living, according to a study led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
-
Archive: Egg Donors Should be Told of Possible Stem Cell Use, UCSF Group Says
A UCSF group recommends that egg and sperm donors for in-vitro fertilization be provided information on possible use of embryos in stem cell research.
-
Archive: Speaker Pelosi Hears Economic Stimulus Success Stories at UCSF
UCSF Chancellor Sue Desmond-Hellmann told House Speaker Nancy Pelosi federal economic stimulus funds will help University scientists conduct “biomedical research that literally will change the world.”
-
Archive: Regional media cover groundbreaking UCSF textbook on lesbian health
-
Archive: New kidney transplant drug effective in humans, UCSF study finds
UCSF nephrologist Flavio Vincenti, MD, is the lead author of a paper in the March 2010 issue of the <i>American Journal of Transplantation</i> that reports results from a Phase III clinical trial for a new drug that selectively blocks immune suppression for kidney transplants. The drug, belatacept, is given to kidney-transplant recipients to prevent the immune system from rejecting the new organ. Vincenti and his co-investigators found that belatacept may be as effective as the commonly used anti-rejection drug cyclosporine, but with fewer side effects and superior kidney function after 12 months.
-
Archive: Two UCSF Scientists to Receive Prestigious Dementia Research Honor
Two UCSF scientists have been selected for the American Academy of Neurology’s prestigious Potamkin Prize, for their “outstanding achievements” in research on dementias.
-
Archive: SF Examiner cover story focuses on UCSF, Mission Bay biotech
-
Archive: UCSF enters drug discovery agreement with Genentech
UCSF has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover and develop drug candidates for neurodegenerative diseases.
-
Archive: Two UCSF Scientists to Receive Prestigious Potamkin Prize for Dementia Research
Two UCSF scientists have been selected for the prestigious Potamkin Prize for their “outstanding achievements” in dementia research.
-
Archive: NIH stem cell guidelines should be modified, UCSF team reports
A UCSF team, led by bioethicist Bernard Lo, MD, recommends that the National Institutes of Health ethics guidelines for embryonic stem cell research be modified to better protect the rights of individuals donating egg or sperm to patients undergoing in vitro fertilization.